Update on antibiotics for infection control in cystic fibrosis.
about
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosisAztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review.Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings.Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis.Predisposing factors for nephrolithiasis and nephrocalcinosis in cystic fibrosis.Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa.
P2860
Update on antibiotics for infection control in cystic fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on antibiotics for infection control in cystic fibrosis.
@en
Update on antibiotics for infection control in cystic fibrosis.
@nl
type
label
Update on antibiotics for infection control in cystic fibrosis.
@en
Update on antibiotics for infection control in cystic fibrosis.
@nl
prefLabel
Update on antibiotics for infection control in cystic fibrosis.
@en
Update on antibiotics for infection control in cystic fibrosis.
@nl
P2093
P2860
P356
P1476
Update on antibiotics for infection control in cystic fibrosis.
@en
P2093
Karen McCoy
Kimberly Novak
Stephen Kirkby
P2860
P304
P356
10.1586/ERI.09.82
P577
2009-10-01T00:00:00Z